Evidence is labelled on each development below (company-reported, regulatory filing or government record), not on the company as a whole. Coverage is not an offer to invest. Private ownership does not imply available shares. Next scheduled recheck: Nov 27, 2026.
Timeline
Nothing published for Paradromics yet. That can simply mean nothing material was filed or awarded in our coverage window.
Profile
- Legal name
- Paradromics, Inc.
- SEC filer
- CIK 0001668302 ↗
- Incorporated
- DE
- Coverage
- Offering notices + any filings + federal awards
Watch Paradromics
Anything new from Paradromics lands in your digest, with the source beside it. Following is about information, never an investment action. Up to 10 companies or frontiers on Pro, $49/month.
Follow this companyPreview a sample digestPrivate offerings reported to the SEC (Form D)
A Form D is a notice a company files after selling securities without a public registration. Amount sold is cumulative for that offering as reported by the company; an amendment (D/A) updates an earlier notice, so rows are not added together. None of these is a valuation or an open offer.
| Filed | Form | Amount sold | Offering size | First sale | Investors | Exemption | Record |
|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | D/A | $50.1 million | $51.0 million | Mar 21, 2023 | 53 | Rule 506(b) | SEC ↗ |
| Apr 5, 2023 | D | $33.0 million | $34.6 million | Mar 21, 2023 | 44 | Rule 506(b) | SEC ↗ |
| Sep 21, 2022 | D | $8.9 million | $8.9 million | Feb 17, 2022 | 9 | Rule 506(b) | SEC ↗ |
| Oct 19, 2021 | D/A | $28.2 million | $28.2 million | Jan 15, 2021 | 42 | Rule 506(b) | SEC ↗ |
| Jul 23, 2021 | D/A | $20.0 million | $20.0 million | Jan 15, 2021 | 42 | Rule 506(b) | SEC ↗ |
| Feb 1, 2021 | D | $4.1 million | $10.0 million | Jan 15, 2021 | 13 | Rule 506(b) | SEC ↗ |
| Apr 15, 2019 | D | $1.4 million | $3.0 million | Mar 29, 2019 | 6 | Rule 506(b) | SEC ↗ |
US federal awards
From USAspending.gov. Obligated is money the government has committed, not company revenue and not the contract’s potential ceiling. Outlays is what has actually been paid. Totals: $3.2 million obligated, $3.2 million paid out across 1 award.
| Agency | Description | Obligated | Paid out | Period | Record |
|---|---|---|---|---|---|
| National Institutes of Health | DEVELOPMENT AND EVALUATION OF NOVEL HIGH-DENSITY INTRACORTICAL MICROELECTRODE ARRAYS FOR CLINICAL APPLICATIONS - PROJECT SUMMARY PARADROM… | $3.2 million | $3.2 million | Sep 10, 2021 – Aug 31, 2024 | USAspending ↗ |